Couple of questions: Why didn't Novartis issue this press release and why is there no Novartis press contact on the release???
SHENZHEN, China,
Nov. 9 /PRNewswire-FirstCall/ - Hard To Treat Diseases (HTDS.PK)
www.htdsmedical.com, announced today that Novartis, a
US$41 billion international healthcare company, is acquiring an 85% stake in HTDS' H1N1 Vaccine partner, Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd., for
US$125 million. Novartis of
Switzerland will begin a five-year,
$1 billion China initiative with two aims: the company will dramatically increase its investment in its China R&D facility, and it will seek to make
China one its top three markets worldwide....
LINK
No comments:
Post a Comment